| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMAX | common shares | Options Exercise | $0 | +3.37K | +18.77% | $0.00 | 21.3K | Mar 7, 2023 | Direct | F1 |
| transaction | IMAX | common shares | Options Exercise | $0 | +1.45K | +6.81% | $0.00 | 22.8K | Mar 7, 2023 | Direct | F1 |
| transaction | IMAX | common shares | Options Exercise | $0 | +1.71K | +7.49% | $0.00 | 24.5K | Mar 7, 2023 | Direct | F1 |
| transaction | IMAX | common shares | Options Exercise | $0 | +562 | +2.3% | $0.00 | 25K | Mar 7, 2023 | Direct | F1 |
| transaction | IMAX | common shares | Options Exercise | $0 | +2.47K | +9.88% | $0.00 | 27.5K | Mar 7, 2023 | Direct | F1 |
| transaction | IMAX | common shares | Tax liability | -$68.7K | -3.73K | -13.55% | $18.43 | 23.8K | Mar 7, 2023 | Direct | F2 |
| transaction | IMAX | common shares | Award | $0 | +5.9K | +24.78% | $0.00 | 29.7K | Mar 7, 2023 | Direct | F3 |
| transaction | IMAX | common shares | Tax liability | -$44.5K | -2.42K | -8.14% | $18.43 | 27.3K | Mar 7, 2023 | Direct | F4 |
| holding | IMAX | common shares (opening balance) | 18K | Mar 7, 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMAX | restricted share units | Options Exercise | $0 | -3.37K | -100% | $0.00* | 0 | Mar 7, 2023 | common shares | 3.37K | $0.00 | Direct | F1, F5, F6, F7, F10 |
| transaction | IMAX | restricted share units | Options Exercise | $0 | -1.45K | -100% | $0.00* | 0 | Mar 7, 2023 | common shares | 1.45K | $0.00 | Direct | F1, F5, F6, F8, F10 |
| transaction | IMAX | restricted share units | Options Exercise | $0 | -1.71K | -50% | $0.00 | 1.71K | Mar 7, 2023 | common shares | 1.71K | $0.00 | Direct | F1, F5, F6, F7, F10 |
| transaction | IMAX | restricted share units | Options Exercise | $0 | -562 | -49.13% | $0.00 | 582 | Mar 7, 2023 | common shares | 562 | $0.00 | Direct | F1, F5, F6, F9, F10 |
| transaction | IMAX | restricted share units | Options Exercise | $0 | -2.47K | -33.33% | $0.00 | 4.95K | Mar 7, 2023 | common shares | 2.47K | $0.00 | Direct | F5, F6, F7, F10 |
| transaction | IMAX | restricted share units | Award | $0 | +10.9K | $0.00 | 10.9K | Mar 7, 2023 | common shares | 10.9K | $0.00 | Direct | F5, F6, F7, F10 |
| Id | Content |
|---|---|
| F1 | Represents the conversion upon vesting of restricted share units into common shares. |
| F2 | Mr. Weissman is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit transactions. |
| F3 | Represents the conversion of vested performance stock units into common shares granted by the Company on March 7, 2020. The shares earned are based on the level of achievement on the EBITDA performance conditions over the three year performance period. |
| F4 | Mr. Weissman is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the performance share unit transactions. |
| F5 | Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation. |
| F6 | Each restricted share unit is the economic equivalent of one common share of IMAX Corporation. |
| F7 | The restricted share units vest and will be converted to common shares in three equal installments on each of the first three anniversaries of the grant date. |
| F8 | The restricted share units vest and will be converted to common shares in two equal installments on each of the first two anniversaries of the grant date. |
| F9 | The restricted share units vest and will be converted to common shares in three installments: 562 on each of March 7, 2022 and March 7, 2023 and 582 on March 7, 2024. |
| F10 | This represents the number of restricted share units for this transaction only. Mr. Weissman's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 16,884, 18,093 and 27,266, respectively. The number of outstanding options reflects the expiration of options to purchase 3,501 common shares on March 7, 2023. Mr. Weissman did not receive any value in connection with such expiration; therefore, such expiration is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended, under Rule 16b-6(d). |